Immune recognition and immunotherapy in hematological malignancies

被引:0
|
作者
Orsini, E
Guarini, A
Torelli, G
Foá, R
机构
[1] Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy
[2] Univ Turin, Dipartimento Sci Biomed & Oncol Umana, Turin, Italy
关键词
immunotherapy; immunorecognition; immunoplasty; hematological neoplasms;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the present review, we shall discuss how immunotherapy has, over the last 15 years, become a prominent part of the therapeutic armamentarium for different types of hematological malignancies. We will also focus on new prospects in rapid and promising development, as well as on possibilities of inducing immune-mediated recognition of leukemia and lymphoma cells.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 50 条
  • [31] Immunotherapy in hematological malignancies: recent advances and open questions
    Tawfik, Essam A.
    Aldrak, Norah A.
    Albrahim, Shahad H.
    Alzahrani, Dunia A.
    Alfassam, Haya A.
    Alkoblan, Samar M.
    Almalik, Abdulaziz M.
    Chen, Kok-Siong
    Abou-Khalil, Rana
    Shah, Khalid
    Zaidan, Nada M.
    IMMUNOTHERAPY, 2021, 13 (14) : 1215 - 1230
  • [32] The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies
    Caserta, Santino
    Cancemi, Gabriella
    Murdaca, Giuseppe
    Stagno, Fabio
    Di Gioacchino, Mario
    Gangemi, Sebastiano
    Allegra, Alessandro
    BIOMEDICINES, 2024, 12 (09)
  • [33] Antigen Loss after Targeted Immunotherapy in Hematological Malignancies
    Zhou, Ting
    Wang, Hao-Wei
    CLINICS IN LABORATORY MEDICINE, 2021, 41 (03) : 341 - 357
  • [34] Discovery and application of immune biomarkers for hematological malignancies
    Zafeiris, Dimitrios
    Vadakekolathu, Jayakumar
    Wagner, Sarah
    Pockley, Alan Graham
    Ball, Graham Roy
    Rutella, Sergio
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (11) : 983 - 1000
  • [35] EXOGENOUS AND ENDOGENOUS IMMUNE TARGETING OF HEMATOLOGICAL MALIGNANCIES
    Thomas, Paul
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [36] EXOGENOUS AND ENDOGENOUS IMMUNE TARGETING OF HEMATOLOGICAL MALIGNANCIES
    Thomas, Paul
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [37] Molecular Signatures of Immune Pressure and Immune Escape in Hematological Malignancies
    Pagliuca, Simona
    Gurnari, Carmelo
    Kewan, Tariq
    Bahaj, Waled
    Mori, Minako
    Terkawi, Laila
    Haddad, Christopher
    Nautiyal, Ishani
    Visconte, Valeria
    Maciejewski, Jaroslaw P.
    BLOOD, 2021, 138
  • [38] "ABC" of Immunotherapy in Hematological Malignancies horizontal ellipsis Promise ... and Perils
    Bajpai, Jyoti
    Philip, Deepa Susan Joy
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (02) : 106 - 114
  • [39] TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
    Jin, Shenhe
    Zhang, Ye
    Zhou, Fengping
    Chen, Xiaochang
    Sheng, Jianpeng
    Zhang, Jin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies
    Di Ianni, Mauro
    Falzetti, Franca
    Carotti, Alessandra
    Terenzi, Adelmo
    Bonifacio, Elisabetta
    Reisner, Yair
    Velardi, Andrea
    Aversa, Franco
    Martelli, Massimo F.
    BLOOD, 2009, 114 (22) : 4 - 4